细胞因子在化学抗原受体T细胞治疗中的性作用
Carli M Stewart1,2,3, Elizabeth L Siegler1,4, Saad S Kenderian1,4,5,6
1T Cell Engineering, Mayo Clinic, Rochester, Minnesota.
Cancer immunology research
|December 1, 2025
概括
化学抗原受体 (CAR) T细胞疗法对癌症治疗有希望,但面临着持久反应和毒性的挑战. 目前正在探索细胞因子调节以提高CAR T细胞的疗效和管理副作用.
科学领域:
- 免疫学和癌症治疗疗法
背景情况:
- 化学抗原受体 (CAR) T细胞疗法已经改变了癌症治疗.
- 持久反应仍然有限,毒性需要密切监测.
- 细胞因子被认为是CAR T细胞疗效和毒性的关键调解剂.
研究的目的:
- 审查细胞因子在CAR T细胞治疗中的作用.
- 探索特定细胞因子 (IFNγ,IL2,IL4,IL10) 对CAR T细胞反应和毒性的悖论性影响.
- 在此背景下,讨论影响细胞因子性变异的因素.
主要方法:
- 关于细胞因子和CAR T细胞疗法的现有研究的文献综述.
- 对细胞因子参与的历史和最近发现的分析.
- 讨论导致细胞因子性变化的因素.
主要成果:
- 细胞因子显著影响CAR T细胞治疗的有效性和副作用.
- 像IFNγ,IL2,IL4和IL10这样的特定细胞因子表现出复杂的,有时是矛盾的角色.
- 了解这些作用对于优化治疗结果至关重要.
结论:
- 细胞因子调节是改善CAR T细胞疗法的关键策略.
- 需要进一步的研究来阐明细胞因子的类效应.
- 向细胞因子通路可能会提高CAR T细胞的疗效并降低毒性.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
T Cell Activation and Clonal Selection
14.6K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.6K
T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K


